Mediatech and GlobalStem Form Strategic Alliance
News Nov 10, 2006
Mediatech contributes over 20 years of cGMP experience in the manufacture of sterile solutions while GlobalStem brings a wealth of knowledge and research in the field of embryonic stem cells (ESC).
Pluripotent ES cells are capable of self-renewal while maintaining the malleability to differentiate into other major cell types in the body.
This gives promise to the technology of cell replacement therapies aimed at remedying disease such as diabetes, Parkinson's, spinal cord injuries and stroke.
Human ES cells also provide a model for the study of normal human development.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019